All News

Oshea.png

RheumNowLive On Demand: Development & Use of JAK Inhibitors - Dr. John O'Shea

d RheumNow

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Read Article
Matteson.png

RheumNowLive On Demand: The History of Steroids - Dr. Eric Matteson

d RheumNow

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Read Article
Weinblatt.png

RheumNowLive On Demand: MTX Impact in RA - Dr. Michael Weinblatt

d RheumNow

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Read Article
Holers.png

RheumNowLive On Demand: Pre-Clinical RA - Dr. Michael Holers

d RheumNow

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Read Article
Screenshot%202019-04-01%2016.48.28.png

RheumNowLive On Demand: Infection Prevention and Management with Newer Agents - Jack Cush, MD

d RheumNow

A clip from RheumNow Live On Demand. You can access the full library of content from the meeting.

Read Article
RN.podcast.resized.jpg

RheumNow Podcast – Loretta Lynn Arthritis (3.29.19)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com.

Read Article
xray%20spine%20films_0.jpg

FDA Approves Cimzia for Non-Radiographic Axial Spondyloarthritis

d Jack Cush, MD

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis called non-radiographic axial spondyloarthritis (nr-axSpA), with objective signs of inflammation.

Read Article
lung%2Cbright.jpg

For RA With COPD, Abatacept is Safe

d RheumNow

Patients with rheumatoid arthritis (RA) who also had chronic obstructive pulmonary disease (COPD) had no increased risk of serious respiratory complications when treated with abatacept (Orencia), a large claims-based analysis found.

Read Article
T%20cell.jpg

Best of 2019 - Ups and Downs with Abatacept

d Jack Cush, MD

Two recent studies have examined the effect of starting abatacept upon the risk of serious hospitalized infections or cancer, showing divergent results from claims data analyses.

Read Article
Following along with #RNL2019 for free! Very slick format. Dr. Conaghan echoing my recent thoughts on U/S from Episode 32 on TaSER and ARCTIC trials: don't use for TtT, but important role when diagnosis uncertain and has prognostic value. @UltrasoundRheum @uptoTate @RheumNow https://t.co/mnweGvGkaw
Mike Putman EBRheum ( View Tweet)
Dr Phil Conaghan on the similarity between OA and PsA #RNL2019 https://t.co/za9YDAWilE
Dr. John Cush RheumNow ( View Tweet)
Took away so much from #RNL2019, but most importantly took a photo with the Godfather of rheumatology @RheumNow! #celebritiesinrheumatology https://t.co/EvXrUXJUGc
Dima Nimri Dima_Nimri ( View Tweet)
The genetics of ANKYLOSING SPONDYLITIS. #RNL2019 - Dr. John Reveille https://t.co/wIszzNqU01
Dr. John Cush RheumNow ( View Tweet)
Dr Carol Langford lecturing at S Carolina Rheum Assn. 1) EGPA usually ANCA negative. 2) a +ANCA does not = a Dx of Vasculitis. 3) +ANCA has a predictive value=90% if renal dz present; but PPV down to 30-60% if only sinus & pulmonary dz present. https://t.co/RfIQEUliRb
Dr. John Cush RheumNow ( View Tweet)
340 CCP+ persons without followed for 1047 PYrs = 21.5% developed RA. Risk of RA progression increased w/ CCP level. 46.0% of high level CCP patients progressedto RA by 5 years. High vs low CCP were 5 times more likely to get RA (HR 4.83, 95%CI 2.51-9.31). https://t.co/V3cRnMzerw

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Give them an inch... Patients with the urge to change their meds | RheumNow - https://t.co/GZfy9HJ55q

Links:

Dr. John Cush RheumNow ( View Tweet)

Claims data analysis of 11,248 matched patients starting abatacept or TNFi showed the risk of hospitalized infection was 37 ABA vs 47 TNFi (HR 0.78; 95% CI 0.64-0.95). Thus ABA was associated with a 22% less risk any hospitalized infection. https://t.co/Ij6b0IYcAZ

Links:

Dr. John Cush RheumNow ( View Tweet)

A cross-sectional study included 1276 RA outpatients showed the prevalence of dysfunctional LBP was 32.8%. Risk factors include BMI (OR 1.116; P < 0.001), onset age, disease duration of RA, MTX use, vertebral Fx, facet erosion, DAS-28CRP, pelvic tilt https://t.co/tg8cRImHdM

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Smoking & RA | RheumNow - Smoking ignites, worsens RA. How to stop smoking. https://t.co/1K1Lal8KRB

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Pushing to LDAS or Remission | RheumNow - Great response in PsA, but is it enough? https://t.co/K7q4NrSOrN

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×